Cardiac pacemaker devices are small, battery-operated devices that senses heart beating irregularities and sends a signal to heart to makes it beat at the adequate pace. A pacemaker may also be used to treat fainting spells (syncope), congestive heart failure, and hypertrophic cardiomyopathy. Pacemakers are either external or implanted just under the skin of the chest during a minor surgical procedure. Cardiac pacemaker is a cardiac rhythm management device composed of a generator and lead that sets heart rhythm by sending electrical impulse to the heart. The global cardiac pacemaker market is growing at a significant pace due to rise in the number of cases of bradycardia, increase in geriatric population, and technological advancements. Although, North America dominates the market, large potential patient base in Asia Pacific region is likely to create an opportunity for cardiac pacemaker manufacturers to record high growth in revenue and market share during the forecast period.
The global cardiac pacemakers market report estimates the market size (Revenue US$ million – 2014 to 2021) for key market segments based on device type (external, implantable and wearable), underlying technologies (bi-ventricular, single chamber and dual pacemaker), and forecasts growth trends (CAGR% – 2017 to 2021).
The global cardiac pacemakers market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cardiac pacemakers market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global cardiac pacemakers market and included in this report are Medtronic, Boston Scientific Corporation, St. Jude Medical, BIOTRONIK SE & Co. KG, SORIN Group, Cook Medical, and Medico S.p.A.